Insider Trading April 30, 2026 12:04 PM

SuRo Capital Corp Director Ronald M. Lott Executes Indirect Stock Sale

The transaction involved over $137,000 in shares held via a family trust as SSSS shares trade near annual highs.

By Jordan Park SSSS
SuRo Capital Corp Director Ronald M. Lott Executes Indirect Stock Sale
SSSS

Ronald M. Lott, a director at SuRo Capital Corp. (NASDAQ:SSSS), has completed an indirect sale of 10,669 shares of the company's common stock. The transaction, which took place on April 28, 2026, was executed through holdings managed by the Ronald M. Lott Family Trust. This divestment occurred amid a period of significant price appreciation for SuRo Capital Corp., with the stock recently trading near its 52-week high and delivering substantial returns over the previous twelve months.

Key Points

  • Director Ronald M. Lott sold 10,669 shares via a family trust at a weighted average price of $12.90.
  • SuRo Capital Corp. saw a massive revenue beat of 233.11% in Q4 2025, despite an EPS miss of -292.45%.
  • The stock has experienced high volatility and growth, returning 201% over the last year.

A recent regulatory filing has disclosed that Ronald M. Lott, a member of the board of directors at SuRo Capital Corp. (NASDAQ:SSSS), has disposed of a portion of his holdings in the company. On April 28, 2026, Mr. Lott facilitated an indirect sale of 10,669 shares of common stock. The total value of this transaction is estimated to be approximately $137,630, based on a weighted-average execution price of $12.90 per share.

The ownership structure behind the sale involves the Ronald M. Lott Family Trust, where Mr. Lott serves as both a beneficiary and a trustee. While the shares were moved through this trust, Mr. Lott has disclaimed beneficial ownership of these specific shares, except for the extent of his own pecuniary interest in them.


Market Context and Share Performance

This insider transaction occurred while SuRo Capital Corp. shares were maintaining a strong market position. At the time of reporting, SSSS was trading at $13.29 per share, placing it in close proximity to its 52-week high of $13.65. The stock has demonstrated significant momentum over the past year, yielding an exceptional return of 201%.

Despite the sale, the Ronald M. Lott Family Trust maintains a position in the company consisting of 10,669 shares. Furthermore, Mr. Lott holds a direct stake of 7,812 shares. This direct holding includes restricted shares that were issued under the company's 2019 Equity Incentive Plan. These specific shares are scheduled to vest in their entirety on either May 28, 2026, or on the date of the upcoming annual meeting of stockholders, whichever occurs first.

Financial Overview and Recent Earnings

In examining the broader financial health of SuRo Capital Corp., recent quarterly data reveals a complex performance picture. During the reporting of its fourth-quarter 2025 earnings, the company exhibited a notable gap between its revenue and earnings per share (EPS). While the reported revenue reached $556.3 million - significantly exceeding the anticipated $167 million by 233.11% - the EPS came in at -$0.79. This figure was lower than the forecasted -$0.2013, representing a discrepancy of -292.45%.

Additionally, SuRo Capital Corp. currently offers its shareholders a dividend yield of 7.6%.


Key Analysis Points

  • Insider Divestment Amidst Growth: The sale by a director occurs while the stock is trading near its annual peak, following a year characterized by massive capital appreciation for shareholders.
  • Revenue vs. Earnings Divergence: The most recent quarterly results highlight a significant volatility in profitability metrics, where revenue vastly outperformed expectations even as earnings per share missed targets by a wide margin.
  • Dividend Stability: Despite the earnings discrepancy, the company maintains a dividend yield of 7.6%, which is a key metric for income-oriented investors.

Sector Impact and Market Dynamics

These developments primarily impact the financial services and investment management sectors. Large variances between revenue and EPS can influence how institutional investors value asset management firms, particularly when assessing the quality of earnings versus top-line growth.


Risks and Uncertainties

  • Earnings Volatility: The significant variance in the fourth-quarter 2025 EPS relative to forecasts represents a risk factor regarding the company's ability to meet bottom-line expectations.
  • Concentration of Vesting: The upcoming vesting of restricted shares in May 2026 introduces potential near-term changes to the direct holding structures of company leadership.

Related Market Activity

In a separate movement within the broader market, Shutter Rock Capital Corp has experienced various shifts in analyst sentiment. Citizens recently raised its price target for Shutter Rock Capital to $15.00 from $13.00 while maintaining a Market Outperform rating, pointing toward a preliminary first-quarter 2026 net asset value of at least $14 per share. This follows a previous increase from $11.00 to $13.00 by the same firm. Similarly, BTIG has moved its price target for Shutter Rock Capital up to $12.50 from $10.50, retaining a Buy rating based on anticipated increases in net asset value for the first quarter of 2026.

Risks

  • Significant discrepancy between revenue surprises and earnings per share misses.
  • Potential for future insider selling as restricted shares vest in May 2026.

More from Insider Trading

Marcus & Millichap Director Executes Substantial Common Stock Purchase May 4, 2026 Patterson-UTI CEO Executes Multi-Million Dollar Stock Sale Amidst Year-to-Date Surge May 4, 2026 Snowflake Director Michael Speiser Executes $7.18 Million in Stock Sales May 4, 2026 Edwards Lifesciences Executive Executes Stock Transactions Amid Recent Financial Growth May 4, 2026 Entrada Therapeutics President and COO Executes Stock Sale via Rule 10b5-1 Plan May 4, 2026